Stay updated on aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A notice appears at the top of the page announcing NIH website updates and explaining that some content may use “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-24T20:12:02.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T20:55:25.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site revision label in the footer changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T21:50:58.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    A 403 Forbidden page is now shown, replacing the detailed study information and leaving a minimal header and navigation. The page presents a generic access-denied view rather than the original ClinicalTrials.gov study record contents.
    Difference
    17%
    Check dated 2026-09-19T20:35:21.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The study record now shows Revision: v3.6.6, replacing the previous v3.6.5 tag. This updates the page metadata to reflect a new revision without changing the study details.
    Difference
    0.1%
    Check dated 2026-08-29T18:45:17.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page now displays a 500 internal server error indicating the study record is temporarily unavailable. This replaces the previous content with an error message.
    Difference
    16%
    Check dated 2026-08-08T15:25:00.000Z thumbnail image

Stay in the know with updates to aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page.